Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TE vs GSK✓SelectedUSD · GSKTE vs GSK performance historyLatest closeAs of-3.05%11/13
Stock and ETF performance explorer

TE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+9.1%
GSK return
+65.8%
Excess return
-56.7%
Maximum drawdown
-84.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%+0.5%-3.6%-3.0%
7D-19.1%+1.1%-20.2%-18.9%
30D-34.1%+6.3%-40.5%-33.6%
3M-60.1%+1.8%-61.9%-59.9%
6M-66.0%+1.7%-67.6%-65.8%
YTD-71.4%+6.5%-78.0%-71.4%
1Y-45.3%+9.5%-54.8%-45.6%
3Y+9.1%+65.3%-56.2%-12.4%
All+9.1%+65.8%-56.7%-12.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling